Difference between revisions of "PET Amyloid Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
m (PET Amyloid Profile Development)
m (PET Amyloid Meetings/Call Summaries)
(40 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
:Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
 
:Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
  
:Secretary: Julie Lisiecki
+
:RSNA Staff Support: Julie Lisiecki
 
* [http://tinyurl.com/QIBA-PET-Amyloid-Roster Roster]
 
* [http://tinyurl.com/QIBA-PET-Amyloid-Roster Roster]
  
Line 20: Line 20:
 
==PET Amyloid Meetings/Call Summaries==
 
==PET Amyloid Meetings/Call Summaries==
  
*[[Media:04_13_2018_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|04.13.2018 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
 
*[[Media:03_09_2018_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|03.09.2018 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
*[[Media:2021_04-09_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL-AMS.pdf|April 9, 2021]]
*[[Media:02_09_2018_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL-dcm.pdf|02.09.2018 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
*[[Media:2021_03-12_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|March 12, 2021]]
*[[Media:01_12_2018_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL-dcm.pdf|01.12.2018 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
*[[Media:2021_02-12_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|February 12, 2021]]
*[[Media:10_13_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|10.13.2017 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
 
*[[Media:09_08_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|09.08.2017 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
 
*[[Media:08_11_2017_QIBA_Amyloid_Biomarker_Ctte_Call_Summary.FINAL.pdf|08.11.2017 QIBA PET Amyloid Biomarker Committee Call Summary]]
+
  
 
'''''[[PET Amyloid BC Call Summaries Archive]]'''''
 
'''''[[PET Amyloid BC Call Summaries Archive]]'''''
Line 33: Line 32:
  
 
*[[Media:QIBA_PET Amyloid_Profile_15June2017-post-public-comment.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02]]  
 
*[[Media:QIBA_PET Amyloid_Profile_15June2017-post-public-comment.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02]]  
 
+
**[[Media:QIBA_PET Amyloid_Profile_02May2018-public-comments-and-responses.pdf | QIBA Public Comments and Responses - 2018-05-02]]
  
 
*[[Media:QIBA_AmyloidPET_15June2017.pdf| QIBA PET Amyloid Profile 2017-06-15]] (''Closed on September 15, 2017'')  
 
*[[Media:QIBA_AmyloidPET_15June2017.pdf| QIBA PET Amyloid Profile 2017-06-15]] (''Closed on September 15, 2017'')  
 +
**[[Media:QIBA_PET_Amyloid_Profile_15June2017_edited_per_public_comment_rl.pdf | QIBA PET-Amyloid DRAFT Profile with tracked changes - 2017-06-15]]
  
 
* [[Media:QIBA PET Amyloid Profilea.pdf| QIBA PET Amyloid Profile 2017-04-28]] (BC Vote to Release for Public Comment Form:  https://goo.gl/forms/0RqF8V6HlXlUNi903)  
 
* [[Media:QIBA PET Amyloid Profilea.pdf| QIBA PET Amyloid Profile 2017-04-28]] (BC Vote to Release for Public Comment Form:  https://goo.gl/forms/0RqF8V6HlXlUNi903)  
Line 58: Line 58:
 
==Presentations and Reports==
 
==Presentations and Reports==
  
 +
*[[Media:08Jun2018_BCMeeting_Amyloid_updated.pdf | 06 08 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
*[[Media:11May2018_BCMeeting_Amyloid_updated.pdf | 05 11 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
*[[Media:13April2018_BCMeeting_Amyloid.pdf | 04 13 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
*[[Media:09March2018_BCMeeting_Amyloid.pdf | 03 09 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 +
 +
*[[Media:09Feb2018_BCMeeting_Amyloid.pdf | 02 09 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
 
*[[Media:12Jan2018_BCMeeting_Amyloid.pdf | 01 12 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith]]
 
*[[Media:12Jan2018_BCMeeting_Amyloid.pdf | 01 12 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith]]
 
*[[Media:QIBA-ADNI Amyloid Data Acquisition Gap Analysis v1.pdf | 01 12 2018 QIBA PET Amyloid Profile / ADNI Gap Analysis - presented by Ms. Matthews]]
 
*[[Media:QIBA-ADNI Amyloid Data Acquisition Gap Analysis v1.pdf | 01 12 2018 QIBA PET Amyloid Profile / ADNI Gap Analysis - presented by Ms. Matthews]]
 +
 +
*[[Media:12Oct2017_BCMeeting_Amyloid.pdf | 10 12 2017 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews]]
  
 
*[[Media:QIBAPETAmyloid_IAW_Conformance-9-9-2016.pdf | 09 09 2016 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith]]
 
*[[Media:QIBAPETAmyloid_IAW_Conformance-9-9-2016.pdf | 09 09 2016 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith]]
Line 71: Line 79:
  
 
*[[Media:02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes.pdf|02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes - presented by Dr. Perlman]]
 
*[[Media:02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes.pdf|02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes - presented by Dr. Perlman]]
 +
 +
==QIBA Funded Projects==
 +
 +
====Round 4====
 +
*[[Media:Amyloid Profile Continued Support with Brain Phantom Development.pdf | Project (X) Amyloid Profile Continued Support with Brain Phantom Development (University of Iowa)]]
 +
 +
====Round 5====
 +
*[[Media:Analyses to Support Amyloid Imaging Profile Development.pdf | Project (A) Analyses to Support Amyloid Imaging Profile Development (ADM Diagnostics, LLC)]]
 +
 +
*[[Media:Amyloid Brain PET Test-Retest Meta-analysis.pdf | Project (E) Amyloid Brain PET Test-Retest Meta-analysis (Johns Hopkins University)]]
 +
 +
*[[Media:A PET-Metabolic Tumor Volume-DRO.pdf | Project (I) A PET-Metabolic Tumor Volume-Digital Reference Object (PET-MTV-DRO) (University of Washington)]]
 +
 +
*[[Media:A Procedure to Facilitate Greater Standardization of PET Spatial Resolution.pdf | Project (J) A Procedure to Facilitate Greater Standardization of PET Spatial Resolution (Johns Hopkins University)]]

Revision as of 20:19, 13 April 2021

Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
RSNA Staff Support: Julie Lisiecki


Project Snapshot

There is a draft Profile, and current outline of the Claim is:

  • SUVr will be the measurand
  • The claim will have two components
1) Cross-sectional: single subject scan
2) Longitudinal: following subject over time

Due to the complexity of having multiple PET Amyloid tracers, a subgroup, the Test-retest Group, has been formed including academics and industry representatives from all of the major PET Amyloid tracer vendors. This group will evaluate the published data on amyloid imaging precision, to determine what level of precision can be claimed in the Profile. The committee’s goal is to have a final draft Profile by December, 2015.

Collaborations: RSNA QIBA is now an affiliate of GAAIN (Global Alzheimer’s Association International Network)

PET Amyloid Meetings/Call Summaries


PET Amyloid BC Call Summaries Archive

PET Amyloid Profile Development

Profile Supporting Material

Working Documents

Presentations and Reports

QIBA Funded Projects

Round 4

Round 5